Cvs Health Corporation (NYSE: CVS) |
|
Price: $67.5700
$0.52
0.776%
|
Day's High:
| $68.265
| Week Perf:
| 0.00
|
Day's Low: |
$ 67.40 |
30 Day Perf: |
6.44 % |
Volume (M): |
550 |
52 Wk High: |
$ 80.75 |
Volume (M$): |
$ 37,518 |
52 Wk Avg: |
$59.21 |
Open: |
$67.57 |
52 Wk Low: |
$43.56 |
|
|
Market Capitalization (Millions $) |
85,183 |
Shares
Outstanding (Millions) |
1,261 |
Employees |
300,000 |
Revenues (TTM) (Millions $) |
372,809 |
Net Income (TTM) (Millions $) |
4,586 |
Cash Flow (TTM) (Millions $) |
359 |
Capital Exp. (TTM) (Millions $) |
2,781 |
Cvs Health Corporation
Company Profile: CVS Health Corporation
Overview: CVS Health Corporation is a prominent player in the U.S. healthcare and retail drugstore sector. It is recognized as one of the largest health services organizations in the country, integrating pharmacy services, retail, and health management solutions.
Financial Performance: As of recent available data, CVS Health Corporation has reported significant net sales, reflecting its robust business operations and broad market presence. The company has successfully adapted to the evolving healthcare landscape, leveraging its diversified service offerings.
Retail Presence: CVS Health operates thousands of retail and specialty pharmacy locations across the United States. With stores in all 50 states and the District of Columbia, CVS is committed to expanding its footprint in key markets, maintaining a strong presence in many of the largest drugstore markets.
Market Position: CVS Health holds a leading market position, boasting a substantial market share in numerous major metropolitan areas. The corporation consistently ranks as one of the top drugstore chains nationally, providing comprehensive health and pharmacy services to millions of customers.
Services Offered: CVS Healths offerings extend beyond traditional retail pharmacy services. The company provides a wide range of health services, including: - Prescription medications and over-the-counter products - Health screenings and immunizations - Pharmacy benefit management through CVS Caremark - Retail clinics through MinuteClinic - Specialty pharmacy services
Commitment to Health Care: CVS Health is dedicated to improving patient outcomes and enhancing the healthcare experience. The company places a strong emphasis on preventative care, medication adherence, and community health initiatives to promote overall wellness.
Vision and Values: The corporation is committed to making health care more accessible, affordable, and simple for its customers. CVS Health values innovation, integrity, and customer service, aiming to transform the health care system to better serve individuals and communities.
---
This updated profile reflects the current operations and strategic direction of CVS Health Corporation, showcasing its role as a leader in the retail and health services landscape.
Company Address: One CVS Drive, Woonsocket, 2895 RI
Company Phone Number: 765-1500 Stock Exchange / Ticker: NYSE CVS
|
|
Customers Net Income grew by |
CVS's Customers Net Profit Margin grew to |
25.36 % |
3.23 %
|
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Cvs Health Corporation
CVS Health Corporation: Amid Challenges, Financial Fundamentals Signal Promising Future In the ever-evolving landscape of the pharmaceutical and retail drugstore industries, CVS Health Corporation (NYSE: CVS) finds itself navigating both a legal storm and a complex financial narrative. Despite facing challenges reflected in its recent second-quarter financial report, CVS is steadfast in its commitment to growth and shareholder value, signaling a bullish outlook for astute investors.
Financial Overview: Navigating Through the Storm The second quarter of fiscal 2024 saw CVS Health reporting revenues of $91.23 billion, a modest advance of 2.601% compared to the previous year. However, the corresponding net income dropped by 4.73%, resulting in earnings per share (EPS) of $1.41. While these figures may appear discouraging, a closer look reveals a differential performance against industry competitors, with others in the pharmacy services and retail drugstore space posting top-line growth of 2.65% for the same period.
|
Announcement
Published Sat, Aug 3 2024 2:49 PM UTC
In an intriguing juxtaposition of corporate turmoil and financial gains, CVS Health Corporation finds itself at the heart of a legal storm while bolstering a positive financial performance through its suppliers. The contrasting narratives unfavorable legal developments and strong supplier sales portray a complex picture of the healthcare giant in recent times. Pomerantz Law ...
|
Stocks on the Move
Published Thu, Jul 25 2024 7:27 PM UTC
The global healthcare industry has undoubtedly faced numerous challenges in recent years, but one company that continues to demonstrate resilience and a commitment to its mission is CVS Health Corporation. A deep dive into various articles provides valuable insights into the company s stock performance, analyst perspectives, and its influence on the pharmacy benefit manageme...
|
Stocks on the Move
Published Fri, Jun 28 2024 2:10 PM UTC
Walgreens Faces Profit Woes and Store Closures Amid Sluggish SpendingIn recent news, Walgreens Boots Alliance, one of the largest pharmacy chains in the United States, has announced a cut in its profit forecast for fiscal 2024. Additionally, the company disclosed plans to close more underperforming stores in the face of weak consumer spending, ultimately causing a 20% drop i...
|
Cvs Health Corporation
CVS Health Corporation, a leading healthcare company, has reported its financial results for the first quarter of 2024. Despite an increase in revenue, the company disclosed a decline in earnings per share (EPS). Revenue grew by 3.704% to $88.44 billion compared to $85.28 billion in the same period last year. However, net profit per share plummeted by -46.67% to $0.88 per share, compared to $1.65 per share in the corresponding period a year ago. Although CVS's revenue growth was below that of its peers in the Pharmacy Services & Retail Drugstore industry, it still reported a 12.76% improvement compared to the same period last year. In the previous reporting period, CVS Health Corporation achieved revenue of $93.81 billion and bottom line earnings of $1.59 per share. However, in the first quarter of 2024, earnings fell by -47.53% to $1,124.000 million from $2,142.000 million in the same period a year before.
|
Per Share |
Current |
Earnings (TTM) |
3.66 $ |
Revenues (TTM) |
295.73 $
|
Cash Flow (TTM) |
0.28 $ |
Cash |
8.72 $
|
Book Value |
60.07 $
|
Dividend (TTM) |
2.66 $ |
|
Per Share |
|
Earnings (TTM) |
3.66 $
|
Revenues (TTM) |
295.73 $ |
Cash Flow (TTM) |
0.28 $ |
Cash |
8.72 $
|
Book Value |
60.07 $ |
Dividend (TTM) |
2.66 $ |
|
|
|
Pharmacy |
|
57.28 % |
of total Revenue |
Front Store |
|
5.44 % |
of total Revenue |
Premiums |
|
32.41 % |
of total Revenue |
Other |
|
4.29 % |
of total Revenue |
Health Care Benefits |
|
34.58 % |
of total Revenue |
Health Care Benefits Premiums |
|
32.4 % |
of total Revenue |
Health Care Benefits Other |
|
1.74 % |
of total Revenue |
Health Services |
|
46.24 % |
of total Revenue |
Health Services Pharmacy network |
|
25.29 % |
of total Revenue |
Health Services Mail specialty |
|
18.04 % |
of total Revenue |
Health Services Other |
|
2.91 % |
of total Revenue |
Health Services Pharmacy |
|
43.33 % |
of total Revenue |
Pharmacy Consumer Wellness |
|
33.98 % |
of total Revenue |
Pharmacy Consumer Wellness Pharmacy |
|
27.94 % |
of total Revenue |
Pharmacy Consumer Wellness Front Store |
|
5.44 % |
of total Revenue |
Pharmacy Consumer Wellness Other |
|
0.59 % |
of total Revenue |
Corporate Other Corporate Other |
|
0.15 % |
of total Revenue |
Corporate Other Corporate Other Premiums |
|
0.01 % |
of total Revenue |
Corporate Other Corporate Other Other |
|
0 % |
of total Revenue |
InterEliminations |
|
-14.95 % |
of total Revenue |
InterEliminations Pharmacy |
|
-14 % |
of total Revenue |
InterEliminations Other |
|
-0.95 % |
of total Revenue |
InterEliminations Health Care Benefits |
|
0.02 % |
of total Revenue |
InterEliminations Health Services |
|
3.5 % |
of total Revenue |
InterEliminations Pharmacy Consumer Wellness |
|
11.43 % |
of total Revenue |
|
|